TP53R175H突变通过调节CORO1A-P38 MAPK通路促进乳腺癌细胞的增殖
Yali Su1, Jiaxuan Zhao1, Haoran Fu1
1Department of Clinical Laboratory, North China University of Science and Technology Affiliated Tangshan Maternal and Child Health Care Hospital-Tangshan, China; Key Laboratory of Molecular Medicine for Abnormal Development and Related Diseases in Tangshan City-Tangshan, China.
Biochemical pharmacology
|February 8, 2024
概括
TP53突变在三阴性乳腺癌中更常见,并且与预后较差有关. TP53R175H突变通过影响CORO1A和p38信号来驱动繁殖,茶叶多显示潜在的治疗抑制作用.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 乳腺癌,特别是三阴性乳腺癌 (TNBC),由于高复发率和转移,存在重大治疗挑战.
- TP53突变在乳腺癌进展中的作用,特别是关于细胞增殖的作用,仍未得到充分研究.
- 了解TP53突变的影响对于改善患者的治疗结果至关重要.
研究的目的:
- 用生物信息学和实验方法研究TP53突变与乳腺癌细胞增殖之间的相关性.
- 为了确定TP53突变的下游目标和潜在的治疗剂.
主要方法:
- 对TP53突变率和患者预后的生物信息分析.
- CCK8测试用于细胞增殖评估.
- 用于蛋白质表达分析的西式涂抹 (p53,p38,p-p38).
- 用mRNA测序来识别TP53的目标基因.
- 分子对接用于药物发现.
主要成果:
- 在TNBC中,TP53突变率更高,与患者预后较差相关.
- TP53R175H突变显著增加了乳腺癌细胞的增殖.
- CORO1A被确定为TP53突变的下游目标,促进扩散和下调p-p38.
- 分子对接表明茶叶聚醇可以通过p53结合来抑制增殖.
结论:
- TP53突变,特别是TP53R175H,是乳腺癌扩散和不良预后的关键驱动因素.
- CORO1A是TP53驱动的扩散的一个关键媒介.
- 茶叶中的多是一种有前途的治疗策略,可以抑制乳腺癌的生长.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K


